Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
A recent commentary pointed to the rollout of Eli Lilly’s next-generation weight loss pill, while raising concerns about competitive dynamics in the fast-growing obesity drug market.
THE APEX TIMES
THE APEX TIMES
Moderna (MRNA) ended the latest trading day at $66.98, down 1.89% from its prior close, according to Yahoo Finance.
THE APEX TIMES
Pfizer (PFE) finished the latest session up 1.28% to $24.48, even as the broader market moved lower, according to the business update cited by Yahoo Finance.
THE APEX TIMES
A market report on July 13 contrasted Abbott Laboratories’ sharp year-to-date slide with Pfizer’s headline-friendly dividend yield, arguing that one stock may reflect business pressure while the other could hide slower-moving risks even after both companies topped quarterly expectations.
THE APEX TIMES
A recent market analysis notes that HCA Healthcare shares have fallen over the past six months despite gains in the broader market, prompting renewed scrutiny of the hospital operator’s post-Q1 outlook.
THE APEX TIMES
A recent options-focused market note highlighted unusual attention around HCA Healthcare shares, underscoring how derivatives markets can preview investor expectations for volatility. Details from the post were not available for this draft review.
THE APEX TIMES
The company says the study appears in The New England Journal of Medicine, extending its involvement in regenerative and genetic therapies for pediatric blood disorders.
THE APEX TIMES
A Yahoo Finance market note argues HCA Healthcare (HCA) could be trading at a large discount relative to peers following a cluster of negative catalysts, including index removals and a bank downgrade.
THE APEX TIMES
The Cambridge, Massachusetts biotech said it will report second-quarter 2026 financial results with a live call and webcast set for 8:00 a.m. ET.
